Fiche centre
Research Site
Bangalore — India
Essais liés2clinical trials
VilleBangalorelocalisation
PaysIndialocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT06742723
Essais cliniques associés
2| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Trastuzumab deruxtecan | Cancer | Phase 4 | NCT06429761 | STRIDE — Phase 4 Study to Assess the Safety of Trastuzumab Deruxtecan, in Indian Patients | ACTIVE_NOT_RECRUITING |
| Baxdrostat/dapagliflozin | Hypertension | Phase 3 | NCT06742723 | BaxDuo-Pacific — A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure | RECRUITING |